New England Biolabs is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for New England Biolabs (China), China, covering academic research published from 2007 to 2023. Read More.
Open Access Percentage
84%
Total
Publications
104
Total Open
Publications
87
Total
Citations
2.5K
Open Access
Percentage
84%
Total
Publications
104
Total Open
Publications
87
Total
Citations
2.5K
Breakdown
Publisher Open
9%
Both
50%
Other Platform Open
25%
Closed
16%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 48%
29
Hybrid 36%
22
No Guarantees 16%
10
Other Platform Open
Domain 53%
41
Preprint 32%
25
Other Internet 31%
24
Institution 9%
7
Public 6%
5
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 39 |
Europe PMC | Domain | 28 |
Unknown Repository | Other Internet | 14 |
bioRxiv | Preprint | 14 |
Research Square | Preprint | 13 |
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART | Other Internet | 6 |
DOI | Other Internet | 5 |
University of Sussex - Sussex Research Online | Institution | 3 |
Semantic Scholar | Public | 3 |
University College London - UCL Discovery | Institution | 2 |